24
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Letter to the Editor

, &
Pages 1835-1836 | Published online: 01 Jul 2009

References

  • Maisel, D., Lim, J.Y., Pollock, W.J. and Liu, P.I. (1998) "Bone marrow necrosis: an entity often overlooked", Ann. aim Lab. Sci. 18, 109–115.
  • Brown, C.H. (1972) "Bone marrow necrosis: a study of 70 cases", John Hopkins Med. J. 131, 189–203.
  • Keating, M.J., O'Brien, S., Kantarjian, H., Plunkett, W., Estey, E., Koller, C., Beran, M. and Freireich, E.J. (1993) "Long term follow-up of patients with chronic lymphocytic leukemia treated with fludarabine as a single agent", Blood 81, 2878–2884.
  • Robak, T. and Kasznicki, M. (2002) "Alkylating agents and nucleoside analogues in the treatment of B cell chronic lymphocytic leukemia", Leukemia 16, 1015–1027.
  • Palomera, L, Azaceta, G., Varo, M.J., Soria, J. and Gutierrez, M. (1998) "Fatal myelofibrosis following fludarabine administration in a patient with indolent lymphoma (letter)", Haematologica 83(11), 1045–1046.
  • Paydas, S., Ergin, M., Baslamisli, F., Yavuz, S., Zorludemir, S., Sahin, B. and Bolat, F.A. (2002) "Bone marrow necrosis: clinicopathologic analysis of 20 cases and review of the literature", Am. J. Hematol. 70, 300–305.
  • Wade, L. and Stevenson, L. (1941) "Necrosis of bone marrow with fat embolism in sickle cell anemia", Am. J. Pathol. 17, 47–54.
  • Kiraly, J.F. and Wheby, US. (1976) "Bone marrow necrosis", Am. J. Med. 60, 361–368.
  • Jassens, A.M., Offner, F.C. and Van Hove, W.Z. (2000) "Bone marrow necrosis", Cancer 88, 1769–1780.
  • Montserrat, E., Bnigues, R.M., Vives Corrons, J.L. and Rozman, C. (1982) "Bone marrow necrosis in chronic lymphocytic leukemia (correspondence)", Clin. Lab. Haematol. 4(1), 94.
  • Hughes, R.G., Islam, A., Lewis, S.M. and Catovsky, D. (1981) "Spontaneous remission following bone marrow necrosis in chronic lymphocytic leukemia", Clin. Lab. Haematol. 3, 173.
  • Aboulafia, D.M. and Demirer, T. (1995) "Fatal bone marrow necrosis following fludarabine administration in a patient with indolent lymphoma", Leuk. Lymphoma 19, 181–184.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.